Intellia Therapeutics (NTLA) Price to Sales (2016 - 2026)
Intellia Therapeutics' (NTLA) Price to Sales was 39.81 for Q2 2026, up 113.0% from 18.69 a year earlier and up 70.4% from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Price to Sales (2016 - 2026) Analysis & Trends
For FY2025, Price to Sales at Intellia Therapeutics was 15.45, down 24.8% from FY2024.
- By year, Price to Sales came in at 20.56 in FY2024 (-73.7%), 78.17 in FY2023 (+34.1%), 58.31 in FY2022 (-78.1%) and 266.46 in FY2021 (+328.9%).
- The Q2 2026 figure ranks as the highest quarterly Price to Sales since Q3 2024.
- Year over year, Price to Sales gained in two of the last eight quarters, with an average decline of 13.6%.
- The high point for year-over-year Price to Sales in five years was Q4 2021 (growth of 328.9%); the low point was Q4 2022 (a decline of 78.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 23.36 (Q1 2026), 15.45 (Q4 2025) and 34.76 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Intellia Therapeutics | 1.72 Bn | 1.72 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.81 |
| Mar 31, 2026 | 23.36 |
| Dec 31, 2025 | 15.45 |
| Sep 30, 2025 | 34.76 |
| Jun 30, 2025 | 18.69 |
| Mar 31, 2025 | 16.15 |
| Dec 31, 2024 | 20.56 |
| Sep 30, 2024 | 48.55 |
| Jun 30, 2024 | 47.85 |
| Mar 31, 2024 | 50.38 |
| Dec 31, 2023 | 78.17 |
| Sep 30, 2023 | 54.42 |
| Jun 30, 2023 | 67.93 |
| Mar 31, 2023 | 61.40 |
| Dec 31, 2022 | 58.31 |
| Sep 30, 2022 | 83.38 |
| Jun 30, 2022 | 86.76 |
| Mar 31, 2022 | 145.16 |
| Dec 31, 2021 | 266.46 |
| Sep 30, 2021 | 372.21 |
API Access
Intellia Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();